Literature DB >> 23737422

Psychopharmacological treatments in children and adolescents. Adequate use or abuse?

Helmut Remschmidt1.   

Abstract

Entities:  

Year:  2013        PMID： 23737422      PMCID： PMC3683265          DOI： 10.1002/wps.20036

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  5 in total

1.  Child and adolescent depression: psychotherapeutic, ethical, and related nonpharmacologic considerations for general psychiatrists and others who prescribe.

Authors:  Mary Lynn Dell
Journal:  Psychiatr Clin North Am       Date:  2012-03

Review 2.  Culturally adapted pharmacotherapy and the integrative formulation.

Authors:  Mansoor Malik; James Lake; William B Lawson; Shashank V Joshi
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-10

3.  The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population.

Authors:  Gagan Joshi; Carter Petty; Janet Wozniak; Aude Henin; Ronna Fried; Maribel Galdo; Meghan Kotarski; Sarah Walls; Joseph Biederman
Journal:  J Autism Dev Disord       Date:  2010-11

4.  A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.

Authors:  Joseph Biederman; Gagan Joshi; Eric Mick; Robert Doyle; Anna Georgiopoulos; Paul Hammerness; Meghan Kotarski; Courtney Williams; Janet Wozniak
Journal:  CNS Neurosci Ther       Date:  2010-04       Impact factor: 5.243

5.  A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.

Authors:  Gagan Joshi; Janet Wozniak; Eric Mick; Robert Doyle; Paul Hammerness; Anna Georgiopoulos; Meghan Kotarski; Megan Aleardi; Courtney Williams; Sarah Walls; Joseph Biederman
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-02       Impact factor: 2.576
  5 in total
  1 in total

1.  Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Authors:  Christian J Bachmann; Thomas Lempp; Gerd Glaeske; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.